UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033613
Receipt number R000038333
Scientific Title Randomized controlled trials on prevention of sarcopenia during gastric cancer surgery by exercise and nutrition intervention
Date of disclosure of the study information 2018/08/02
Last modified on 2020/08/03 17:36:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled trials on prevention of sarcopenia during gastric cancer surgery by exercise and nutrition intervention

Acronym

Randomized controlled trials on prevention of sarcopenia during gastric cancer surgery by exercise and nutrition intervention

Scientific Title

Randomized controlled trials on prevention of sarcopenia during gastric cancer surgery by exercise and nutrition intervention

Scientific Title:Acronym

Randomized controlled trials on prevention of sarcopenia during gastric cancer surgery by exercise and nutrition intervention

Region

Japan


Condition

Condition

Gastric Cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Verify the prevention effect of sarcopenia during gastric cancer surgery by exercise and nutrition intervention.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of sarcopenia

Key secondary outcomes

Weight, skeletal muscle mass, perioperative complications, hematological nutritional indicators, duration of postoperative chemotherapy, QOL, exercise habits, physical fitness tests, blood hormone, immunity and inflammatory cytokines


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food Behavior,custom

Interventions/Control_1

Treatment intervention group
Perioperative resistance training, amino acid intake from 3 weeks or more before surgery to 3 months after surgery

Interventions/Control_2

Standard treatment group

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients scheduled to undergo gastric cancer surgery
PS 0-2
Consent has been obtained

Key exclusion criteria

Patients take preoperative chemotherapy.
Exercise training is diagnosed as inappropriate by general condition.
Patients take warfarin.
The doctor in charge judged it to be inappropriate.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Susumu
Middle name
Last name Aikou

Organization

The University of Tokyo

Division name

Department of Bariatric & Metaboric Care

Zip code

113-8655

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411

Email

aikous-tky@umin.ac.jp


Public contact

Name of contact person

1st name Susumu
Middle name
Last name Aikou

Organization

The University of Tokyo

Division name

Department of Bariatric & Metaboric Care

Zip code

113-8655

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411

Homepage URL


Email

aikous-tky@umin.ac.jp


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

RIZAP Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Research Ethics Committee of the Faculty of Medicine of the University of Tokyo

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

Tel

03-5841-0818

Email

ethics@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2018 Year 08 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

24

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 07 Month 13 Day

Date of IRB

2020 Year 07 Month 20 Day

Anticipated trial start date

2017 Year 09 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 08 Month 02 Day

Last modified on

2020 Year 08 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038333


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name